Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update
Teresa Schätzl, Lars Kaiser, Hans‐Peter Deigner
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

A guide for the diagnosis of rare and undiagnosed disease: beyond the exome
Shruti Marwaha, Joshua W. Knowles, Euan A. Ashley
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 228
Pathomechanisms and biomarkers in facioscapulohumeral muscular dystrophy: roles of DUX4 and PAX7
Christopher R. S. Banerji, Peter S. Zammit
EMBO Molecular Medicine (2021) Vol. 13, Iss. 8
Open Access | Times Cited: 57
DUX4 Role in Normal Physiology and in FSHD Muscular Dystrophy
Emanuele Mocciaro, Valeria Runfola, Paola Ghezzi, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3322-3322
Open Access | Times Cited: 43
Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study
Zhiqiang Wang, Liangliang Qiu, Min-Ting Lin, et al.
The Lancet Regional Health - Western Pacific (2021) Vol. 18, pp. 100323-100323
Open Access | Times Cited: 27
Muscular Dystrophies and Therapeutic Potential of Medicinal Plants
Mοhd Saeed, Munazzah Tasleem, Ashanul Haque, et al.
Deleted Journal (2025) Vol. 4, Iss. 1
Open Access
The Unexplored Role of Connexin Hemichannels in Promoting Facioscapulohumeral Muscular Dystrophy Progression
Macarena Díaz‐Ubilla, Mauricio A. Retamal
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 373-373
Open Access
A discrete region of the D4Z4 is sufficient to initiate epigenetic silencing
Ellen Paatela, Frédéric Amant, Danielle C. Hamm, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Evaluating transcriptional alterations associated with ageing and developing age prediction models based on the human blood transcriptome
Iván Durán, Amy Tsurumi
Biogerontology (2025) Vol. 26, Iss. 2
Closed Access
Update on the Molecular Aspects and Methods Underlying the Complex Architecture of FSHD
Valerio Caputo, Domenica Megalizzi, Carlo Fabrizio, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2687-2687
Open Access | Times Cited: 16
Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments
Elisa Duranti, Chiara Villa
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9503-9503
Open Access | Times Cited: 9
Meta-analysis towards FSHD reveals misregulation of neuromuscular junction, nuclear envelope, and spliceosome
Teresa Schätzl, Vanessa Todorow, Lars Kaiser, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Whole-muscle fat analysis identifies distal muscle end as disease initiation site in facioscapulohumeral muscular dystrophy
Linda Heskamp, Augustin C. Ogier, David Bendahan, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 14
P2 Receptor Signaling in Motor Units in Muscular Dystrophy
A. E. Khairullin, С. Н. Гришин, А. У. Зиганшин
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1587-1587
Open Access | Times Cited: 7
DUX4 expression activates JNK and p38 MAP kinases in myoblasts
Christopher M. Brennan, Abby S. Hill, Michael St. Andre, et al.
Disease Models & Mechanisms (2022) Vol. 15, Iss. 11
Open Access | Times Cited: 11
The double homeodomain protein DUX4c is associated with regenerating muscle fibers and RNA-binding proteins
Clothilde Claus, Moriya Slavin, Eugénie Ansseau, et al.
Skeletal Muscle (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview
Malihe Mohamadian, Mandana Rastegar, Negin Pasamanesh, et al.
Journal of Molecular Neuroscience (2021) Vol. 72, Iss. 1, pp. 9-23
Closed Access | Times Cited: 13
Elevated plasma complement components in facioscapulohumeral dystrophy
Chao-Jen Wong, Leo Wang, V. Michael Holers, et al.
Human Molecular Genetics (2021) Vol. 31, Iss. 11, pp. 1821-1829
Open Access | Times Cited: 12
ANT1 overexpression models: Some similarities with facioscapulohumeral muscular dystrophy
Sandrine Arbogast, Heinrich Kotzur, Corinna Frank, et al.
Redox Biology (2022) Vol. 56, pp. 102450-102450
Open Access | Times Cited: 9
Human DUX4 and porcine DUXC activate similar early embryonic programs in pig muscle cells: implications for preclinical models of FSHD
Yee Nip, Sean Bennett, Andrew A. Smith, et al.
Human Molecular Genetics (2023) Vol. 32, Iss. 11, pp. 1864-1874
Closed Access | Times Cited: 5
The Splicing of the Mitochondrial Calcium Uniporter Genuine Activator MICU1 Is Driven by RBFOX2 Splicing Factor during Myogenic Differentiation
Denis Vecellio Reane, Cristina Cerqua, Sabrina Sacconi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 5, pp. 2517-2517
Open Access | Times Cited: 8
Non-myogenic mesenchymal cells contribute to muscle degeneration in facioscapulohumeral muscular dystrophy patients
Lorena Di Pietro, Flavia Giacalone, Elvira Ragozzino, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 7
Management of scapular dysfunction in facioscapulohumeral muscular dystrophy: the biomechanics of winging, arthrodesis indications, techniques and outcomes
İlker Eren, Cemil Cihad Gedik, Uğur Kılıç, et al.
EFORT Open Reviews (2022) Vol. 7, Iss. 11, pp. 734-746
Open Access | Times Cited: 7
MATR3 is an endogenous inhibitor of DUX4 in FSHD muscular dystrophy
Valeria Runfola, Roberto Giambruno, Claudia Caronni, et al.
Cell Reports (2023) Vol. 42, Iss. 9, pp. 113120-113120
Open Access | Times Cited: 4
Muscle Proteome Analysis of Facioscapulohumeral Dystrophy Patients Reveals a Metabolic Rewiring Promoting Oxidative/Reductive Stress Contributing to the Loss of Muscle Function
Manuela Moriggi, Lucia Ruggiero, Enrica Torretta, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1406-1406
Open Access | Times Cited: 1
The Phosphonate Derivative of C60 Fullerene Induces Differentiation towards the Myogenic Lineage in Human Adipose-Derived Mesenchymal Stem Cells
Svetlana V. Kostyuk, Elena V. Proskurnina, Elizaveta S. Ershova, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9284-9284
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top